Virpax Pharmaceuticals (VRPX) announced that it has received a ruling on the lawsuit filed by Scilex Pharmaceuticals (SCLX) and Sorrento Therapeutics, the now bankrupt majority owner of Scilex Pharmaceuticals. The court found in favor of the plaintiffs. However, no damages judgment was specified in the ruling which called for additional proceedings to determine the remedy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VRPX:
